Pancreatic Cancer Research

ResearcherUniversity of BernNo recent work listed

Erik Vassella

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7982-8713; OpenAlex author ID A5032572194. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: 1 paper

Papers 3

  1. Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance. Co-author DOI 10.1158/1078-0432.ccr-17-3401↗
  2. MicroRNA dysregulation in the tumor microenvironment influences the phenotype of pancreatic cancer. Last author DOI 10.1038/modpathol.2017.35↗
  3. PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potential. Co-author DOI 10.1016/j.ejca.2016.06.013↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Martin Wartenberg · 3 shared papers, 2016–2018 · strength 0.21
  2. Eva Karamitopoulou · 3 shared papers, 2016–2018 · strength 0.21
  3. Aurel A. Perren · 2 shared papers, 2016–2018 · strength 0.13
  4. Beat Gloor · 2 shared papers, 2016–2018 · strength 0.13
  5. Mathias Worni · 1 shared paper, 2018 · strength 0.08
  6. Alessandro Lugli · 1 shared paper, 2016 · strength 0.05
  7. José A. Galván · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.